Trials / Completed
CompletedNCT07235137
A Study to Learn How the Study Medicine Called Ibuzatrelvir is Taken up Into the Blood in Healthy Chinese Adults
A Phase 1, Single Arm Study to Evaluate the Pharmacokinetics Following Single Dose of PF-07817883 (Ibuzatrelvir) in Healthy Chinese Adult Participants.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
A study to learn how the study medicine called Ibuzatrelvir is taken up into the blood in healthy Chinese adults.
Detailed description
To evaluate the PK profile of ibuzatrelvir after administration in Chinese healthy participants
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ibuzatrelvir | Ibuzatrelvir will be given by mouth to adult Chinese healthy volunteers |
Timeline
- Start date
- 2025-10-16
- Primary completion
- 2025-11-21
- Completion
- 2025-11-21
- First posted
- 2025-11-19
- Last updated
- 2026-01-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07235137. Inclusion in this directory is not an endorsement.